Clinical Reference · Peer-reviewed · Live

The eye is a window
to the whole body.

A research-grounded reference of the retinal pathologies and systemic biomarkers OCTON reasons across — from sight-threatening disease to early cardiovascular, stroke, renal and neurodegenerative signals. Every claim below is sourced to the peer-reviewed literature.

Ocular conditions
15
Systemic (oculomics) signals
7
Peer-reviewed sources
12
Engine onlineFUNDUS · OD/OS · 45° FOV
Begin clinical scan
Oculomics · the science

One photograph. The body's circulation and its nervous system — visible at once.

The retina is the only tissue where the microvasculature and central-nervous-system neurons can be imaged directly, non-invasively, in a living person. That makes a single fundus photograph a uniquely rich systemic biomarker — a field now formally named oculomics (Wagner et al., 2020). OCTON is built on this premise: what the eye reveals rarely stops at the eye.

The visible microvasculature

The retina is the only place in the body where arteries, veins and capillaries can be photographed directly, without breaking the skin. Their calibre, tortuosity and branching mirror the heart, brain and kidney circulation.

Exposed nervous-system tissue

The retina is a developmental outgrowth of the brain. Its nerve-fibre and ganglion-cell layers thin in step with neurodegeneration — a live, in-vivo window onto conditions like Alzheimer's, Parkinson's and MS.

Non-invasive & scalable

A fundus photo takes seconds, needs no blood draw, and can now be captured on a smartphone. Deep learning turns that image into quantified, whole-body risk — screening at a population scale.

AUC 0.99

Diabetic-retinopathy grading by deep learning matches expert ophthalmologists.

Gulshan, JAMA 2016
5-yr MACE

Age, blood pressure, smoking & cardiac-event risk read from a fundus photo.

Poplin, Nat Biomed Eng 2018
Kidney

Chronic kidney disease detected from the retina alone.

Sabanayagam, Lancet Digital Health 2020
Lifespan

The 'retinal age gap' predicts mortality and incident dementia.

Zhu, Br J Ophthalmol 2022
01 / VESSELS

Vascular retinopathies

4 Conditions
DR-01high Impact

Diabetic Retinopathy

Microvascular damage from chronic hyperglycemia — a direct readout of systemic glucose control.

~1 in 3 people with diabetes; leading cause of working-age blindness worldwide.
Systemic window ·A window onto systemic microvascular disease and glycaemic control.
Key signs
  • Microaneurysms
  • Dot/blot hemorrhages
  • Hard exudates
  • Cotton-wool spots
  • Neovascularization (PDR)
Stages
  • 00No DR
  • 01Mild NPDR
  • 02Moderate NPDR
  • 03Severe NPDR
  • 04Proliferative DR
Evidence
  • DCCT: intensive glucose control cut retinopathy progression by 54% (NEJM, 1993).
  • Deep learning grades DR from fundus photos at AUC 0.99, matching ophthalmologists (Gulshan, JAMA 2016).
HR-02moderate Impact

Hypertensive Retinopathy

Retinal vasculature damage from systemic hypertension — the vessels visibly record blood-pressure injury.

Retinal signs in ~2–15% of non-diabetic adults aged ≥40.
Systemic window ·Grade mirrors systemic blood-pressure damage and target-organ risk.
Key signs
  • Arteriolar narrowing
  • A/V nicking
  • Flame hemorrhages
  • Cotton-wool
  • Papilledema (malignant)
Stages
  • 00No HR
  • 01Mild (K-W I-II)
  • 02Moderate (III)
  • 03Malignant (IV)
Evidence
  • Retinal microvascular abnormalities independently predicted incident stroke — ARIC (Wong, Lancet 2001).
RVO-03high Impact

Retinal Vein Occlusion

Blockage of the central or branch retinal vein — often the first visible sign of vascular disease.

~28 million adults globally; the 2nd commonest retinal vascular disease.
Systemic window ·Strongly associated with hypertension, glaucoma and cardiovascular risk.
Key signs
  • Tortuous dilated veins
  • Flame hemorrhages in distribution
  • Macular edema
  • Cotton-wool spots
Stages
  • 00None
  • 01Branch RVO
  • 02Central RVO
RAO-04high Impact

Retinal Artery Occlusion

A 'stroke of the eye' — sudden painless vision loss and an ophthalmic emergency.

~1–2 per 100,000 per year.
Systemic window ·A stroke-equivalent — mandates urgent stroke/TIA workup (AHA/ASA).
Key signs
  • Pale retina
  • Cherry-red spot
  • Embolus visible in vessel
  • Box-carring
Stages
  • 00None
  • 01Branch RAO
  • 02Central RAO
Evidence
  • Central retinal artery occlusion carries a high risk of subsequent cerebral stroke and is managed as a TIA-equivalent.
02 / MACULA

Macular & retinal disorders

4 Conditions
AMD-05high Impact

Age-related Macular Degeneration

Leading cause of central vision loss in adults 50+.

~200 million people worldwide; rising with an ageing population.
Systemic window ·Shares risk pathways with cardiovascular disease (smoking, lipids, inflammation).
Key signs
  • Drusen deposits
  • RPE pigment changes
  • Geographic atrophy
  • Choroidal neovascularization
Stages
  • 00No AMD
  • 01Early dry
  • 02Intermediate dry
  • 03Late dry / GA
  • 04Late wet / CNV
Evidence
  • AREDS2: an antioxidant + zinc formula slows progression to advanced AMD by ~25% (JAMA, 2013).
ME-06moderate Impact

Macular Edema

Fluid accumulation in the macula impairing central vision.

The commonest cause of vision loss in diabetic eye disease.
Key signs
  • Macular thickening
  • Cystic spaces
  • Hard exudates
  • Loss of foveal reflex
Stages
  • 00None
  • 01Mild
  • 02Moderate
  • 03Severe
Evidence
  • Anti-VEGF therapy improves vision in diabetic macular edema (DRCR.net Protocol T, NEJM 2015).
ERM-07moderate Impact

Epiretinal Membrane

Fibrocellular tissue on the macular surface causing distortion.

Found in ~7–11% of adults on imaging; often age-related.
Key signs
  • Cellophane reflex
  • Macular pucker
  • Distorted vessels
Stages
  • 00None
  • 01Mild (cellophane)
  • 02Moderate
  • 03Severe (macular pucker)
MH-08high Impact

Macular Hole

Full-thickness defect in the foveal retina.

Vitrectomy closes >90% of stage 2–3 holes when treated early.
Key signs
  • Round retinal defect
  • Surrounding cuff of edema
  • Yellow deposits
Stages
  • 00None
  • 01Stage 1 (impending)
  • 02Stage 2-3 (full)
  • 03Stage 4 (with PVD)
03 / OPTIC

Optic nerve & glaucoma

3 Conditions
GL-09high Impact

Glaucoma

Progressive optic neuropathy with retinal ganglion-cell loss — silent until advanced.

~80 million people worldwide; leading cause of irreversible blindness.
Systemic window ·Ganglion-cell/RNFL loss increasingly studied as a neurodegeneration marker.
Key signs
  • Increased cup-to-disc
  • RNFL thinning
  • Notching of rim
  • Disc hemorrhage
Stages
  • 00Low risk
  • 01Suspect
  • 02Definite
Evidence
  • OHTS: lowering intraocular pressure halved progression to glaucoma (Arch Ophthalmol, 2002).
PAP-10high Impact

Papilledema / Raised ICP

Bilateral disc swelling — a neurological emergency marker.

Systemic window ·A visible sign of raised intracranial pressure — demands urgent neuro-imaging.
Key signs
  • Swollen optic disc
  • Blurred margins
  • Hemorrhages on disc
  • Loss of cup
Stages
  • 00None
  • 01Suspected
  • 02Present
ON-11moderate Impact

Optic Neuropathy / Neuritis

Inflammation or atrophy of the optic nerve.

Systemic window ·Often the first presentation of multiple sclerosis.
Key signs
  • Optic disc pallor
  • RNFL thinning
  • Afferent pupillary defect
  • Color desaturation
Stages
  • 00None
  • 01Suspected
  • 02Present
Evidence
  • OCT of the retinal nerve-fibre layer quantifies axonal loss and tracks MS activity.
04 / GENERAL

Other ocular pathologies

4 Conditions
CT-12moderate Impact

Cataract

Clouding of the crystalline lens — graded by fundus clarity.

The world's leading cause of blindness — and fully reversible with surgery.
Key signs
  • Reduced fundus clarity
  • Yellow/brown tint
  • Diffuse opacity
Stages
  • 00None
  • 01Mild
  • 02Moderate
  • 03Dense
RD-13high Impact

Retinal Detachment

Separation of neurosensory retina from RPE — emergency.

~1 in 10,000 per year; sudden floaters/flashes are red flags.
Key signs
  • Retinal tears
  • Subretinal fluid
  • Pigment tobacco dust
  • Wrinkled appearance
Stages
  • 00None
  • 01Suspected
  • 02Present
RP-14moderate Impact

Retinitis Pigmentosa

Inherited photoreceptor degeneration.

~1 in 4,000; commonest inherited retinal dystrophy.
Systemic window ·Can be part of systemic syndromes (e.g. Usher, Bardet-Biedl).
Key signs
  • Bone spicule pigmentation
  • Waxy disc pallor
  • Attenuated vessels
Stages
  • 00Early
  • 01Mid-stage
  • 02Advanced
CN-15high Impact

Choroidal Nevus / Melanoma

Pigmented choroidal lesion — benign vs malignant.

Choroidal melanoma is the commonest primary intra-ocular cancer in adults.
Key signs
  • Pigmented elevated lesion
  • Orange pigment
  • Subretinal fluid
  • Drusen on surface
Stages
  • 00Nevus
  • 01Suspicious
  • 02Melanoma
05 / SYSTEMIC

Systemic risk signals · oculomics

7 Conditions
CV-16moderate Impact

Cardiovascular Risk

The retinal circulation is the body's only directly visible microvascular bed.

Systemic window ·Vessel calibre and tortuosity correlate with coronary artery disease.
Key signs
  • Arteriovenous ratio
  • Vessel tortuosity
  • Fractal dimension
Stages
  • 00Low
  • 01Moderate
  • 02High
Evidence
  • Deep learning reads age, blood pressure, smoking and 5-year cardiac-event risk from a fundus photo (Poplin, Nat Biomed Eng 2018).
ST-17high Impact

Stroke Risk

Retinal arteriolar sclerosis & emboli parallel cerebral small-vessel disease.

Systemic window ·The retinal and cerebral microvasculature share embryology and biology.
Key signs
  • Hollenhorst plaques
  • Arteriolar sclerosis
  • Retinal infarcts
Stages
  • 00Low
  • 01Moderate
  • 02High
Evidence
  • Retinal microvascular signs independently predicted incident stroke — ARIC (Wong, Lancet 2001).
AZ-18moderate Impact

Alzheimer's & Dementia

Retinal β-amyloid deposits & RNFL thinning as an early neurodegeneration marker.

Systemic window ·The retina is CNS tissue — it reflects brain neurodegeneration.
Key signs
  • Retinal Aβ plaques
  • RNFL / GC-IPL thinning
  • Microvascular sparsity
Stages
  • 00Negative
  • 01Positive markers
  • 02Strong markers
Evidence
  • Retinal amyloid-β was imaged in Alzheimer's disease and correlated with brain plaque (Koronyo, JCI Insight 2017).
MS-19moderate Impact

Multiple Sclerosis Signal

Optic-neuritis history plus RNFL thinning tracks demyelination.

Systemic window ·OCT of the retina serves as a non-invasive marker of CNS axonal loss.
Key signs
  • RNFL thinning (esp. temporal)
  • Optic disc pallor
  • History of optic neuritis
Stages
  • 00Negative
  • 01Suggestive
  • 02Strong
AN-20moderate Impact

Anaemia Signal

Retinal pallor & haemorrhages in severe anaemia — and now quantifiable by AI.

Systemic window ·Blood-oxygen and haemoglobin status are visible in the retinal vasculature.
Key signs
  • Retinal pallor
  • Roth spots
  • Cotton-wool spots
Stages
  • 00Negative
  • 01Mild signs
  • 02Severe
Evidence
  • Deep learning estimates haemoglobin and detects anaemia from fundus images (Mitani, Nat Biomed Eng 2020).
KD-21moderate Impact

Chronic Kidney Disease Signal

The retinal microvasculature mirrors the kidney's glomerular circulation.

Systemic window ·Eye and kidney share microvascular biology — a non-invasive renal triage.
Key signs
  • Microvascular rarefaction
  • Overlap with diabetic nephropathy
  • Vessel-calibre change
Stages
  • 00Negative
  • 01Suggestive
  • 02Strong
Evidence
  • A deep-learning algorithm detected chronic kidney disease from retinal photographs (Sabanayagam, Lancet Digital Health 2020).
RB-22moderate Impact

Retinal Biological Age

The retina ages measurably; the gap versus chronological age tracks whole-body health.

Systemic window ·A single photo yields a whole-body ageing biomarker.
Key signs
  • Vascular fractal dimension
  • Vessel density
  • RNFL / GC-IPL thickness
Stages
  • 00Younger than age
  • 01On track
  • 02Accelerated ageing
Evidence
  • A larger 'retinal age gap' predicted higher mortality and incident dementia (Zhu, Br J Ophthalmol 2022).
06 / ONCOLOGY — HIGHLIGHTED BY NASSER

Oncology · Esophageal cancer

4 Conditions
EC-21high Impact

Esophageal Adenocarcinoma

Lower-esophagus / junction cancer on the reflux → Barrett's pathway — fastest-rising GI cancer in the West.

Key signs
  • Chronic GERD history
  • Progressive dysphagia (solids → liquids)
  • Unintentional weight loss
  • Iron-deficiency anemia
  • Central obesity risk profile
Stages
  • 00T1a (endoscopically curable)
  • 01T1b-T2
  • 02T3 / node-positive
  • 03T4 / metastatic
EC-22high Impact

Esophageal Squamous Cell Carcinoma

Upper/mid-esophagus cancer driven by tobacco (smoked & chewed), alcohol and scalding-hot drinks (>65°C, IARC 2A).

Key signs
  • Tobacco + alcohol synergy
  • Betel/areca nut use
  • Very hot beverages (maté)
  • Odynophagia
  • Hoarseness (RLN involvement)
Stages
  • 00Dysplasia
  • 01Localized
  • 02Locally advanced
  • 03Metastatic
EC-23moderate Impact

Barrett's Esophagus (precursor)

Reflux-driven intestinal metaplasia — the surveillance window where cancer is preventable.

Key signs
  • Salmon-colored mucosa on endoscopy
  • Intestinal metaplasia on biopsy
  • ±Dysplasia grading
  • Cytosponge-TFF3 positive
Stages
  • 00No dysplasia
  • 01Low-grade dysplasia
  • 02High-grade dysplasia
  • 03Intramucosal carcinoma
EC-24high Impact

Red Flags & Care Pathway

Persistent dysphagia at any age = urgent endoscopy (2-week-wait standard). OCTON's Voice Live conducts the structured triage interview.

Key signs
  • Progressive dysphagia
  • Weight loss + reflux (≥55)
  • GI bleeding / melaena
  • Endoscopy + biopsy → EUS → PET-CT
  • CROSS / FLOT / immunotherapy era treatment
Stages
  • 00Symptom triage
  • 01Urgent endoscopy
  • 02Staging
  • 03MDT treatment
07 / ONCOLOGY

Oncology · Oral & throat cancer

4 Conditions
OC-25high Impact

Oral Cavity Squamous Cell Carcinoma

Tobacco, alcohol and betel/areca nut driven — the mouth is the one cancer site you can SEE early.

Key signs
  • Non-healing ulcer >3 weeks
  • Red patch (erythroplakia)
  • White patch (leukoplakia)
  • Neck lump
  • Unexplained loose teeth
Stages
  • 00Premalignant disorder
  • 01Stage I-II (70-90% survival)
  • 02Locally advanced
  • 03Recurrent/metastatic
OC-26high Impact

Betel / Areca Nut Disease

IARC Group-1 carcinogen even without tobacco — drives oral submucous fibrosis and cancer across South Asia & the Gulf.

Key signs
  • Paan / gutka / supari use
  • Progressive trismus (mouth stiffening)
  • Burning on spicy food
  • Blanched, rigid mucosa
Stages
  • 00Habit exposure
  • 01Submucous fibrosis
  • 02Dysplasia
  • 03Carcinoma
OC-27moderate Impact

HPV Oropharyngeal Cancer

Tonsil / tongue-base cancer rising in never-smokers — distinctly better prognosis (Ang 2010), vaccine-preventable.

Key signs
  • One-sided sore throat
  • Referred ear pain
  • Neck lump
  • p16-positive histology
Stages
  • 00HPV exposure
  • 01Localized
  • 02Nodal spread
  • 03Metastatic
OC-28moderate Impact

Mouth Self-Exam & Screening

2-minute mirror check monthly; visual screening cut oral-cancer mortality by a third in the Kerala RCT.

Key signs
  • Cheeks & inner lips
  • All tongue surfaces + floor of mouth
  • Gums & palate
  • Anything persisting 3 weeks → specialist
Stages
  • 00Self-exam
  • 01Dental opportunistic check
  • 022-week-wait referral
  • 03Biopsy
08 / CARDIOVASCULAR

Cardiovascular disease & stroke

4 Conditions
CV-29high Impact

Heart Attack (Myocardial Infarction)

The world's #1 killer — 90% of risk is modifiable (INTERHEART). Crushing chest pain >15 min = emergency call, now.

Key signs
  • Crushing central chest pressure
  • Radiation to arm/jaw
  • Sweating + nausea
  • Breathlessness
Stages
  • 00Risk factors
  • 01Angina
  • 02Acute MI
  • 03Heart failure
CV-30high Impact

Stroke & TIA

Think FAST: Face, Arm, Speech, Time. A TIA that 'went away' is the highest-risk emergency of all.

Key signs
  • Face drooping
  • Arm weakness
  • Speech difficulty
  • Sudden vision loss
  • Worst-ever headache
Stages
  • 00TIA
  • 01Ischaemic stroke
  • 02Thrombectomy window
  • 03Rehabilitation
CV-31moderate Impact

The Retina–Heart Window

OCTON's home turf: retinal microvascular signs predicted stroke (Wong 2001); AI reads CV risk from fundus photos (Poplin 2018).

Key signs
  • Arteriolar narrowing
  • AV nicking
  • Retinal hemorrhages
  • Cotton-wool spots
Stages
  • 00Normal vessels
  • 01Grade 1-2 changes
  • 02Grade 3
  • 03Grade 4 (accelerated)
CV-32high Impact

Atrial Fibrillation

An irregular pulse that multiplies stroke risk ~5× — and anticoagulation slashes it. Feel your pulse.

Key signs
  • Irregularly irregular pulse
  • Palpitations
  • Breathlessness
  • Often silent
Stages
  • 00Paroxysmal
  • 01Persistent
  • 02Permanent
  • 03Anticoagulated (protected)
09 / ONCOLOGY

Oncology · Lung cancer

4 Conditions
LC-33high Impact

Non-Small-Cell Lung Cancer

~85% of lung cancer — now treated by molecular profile (EGFR/ALK/PD-L1), not just histology.

Key signs
  • Cough >3 weeks or changing
  • Haemoptysis (any amount)
  • Weight loss
  • Chest/shoulder pain
Stages
  • 00Stage I (surgical, 60-90%)
  • 01Stage II-III
  • 02Stage III (PACIFIC era)
  • 03Stage IV (targeted/immuno)
LC-34high Impact

Small-Cell Lung Cancer

~15%, almost exclusively in smokers — fast-growing, early spread, chemo-sensitive.

Key signs
  • Rapid symptom onset
  • Heavy smoking history
  • Paraneoplastic syndromes
  • Early nodal spread
Stages
  • 00Limited stage
  • 01Extensive stage
LC-35moderate Impact

Low-Dose CT Screening

Proven mortality reduction (NLST −20%, NELSON −24%) for 50-80 with heavy smoking history — massively under-used.

Key signs
  • Age 50-80
  • ≥20 pack-years
  • Current or quit <15 yrs
  • Annual LDCT
Stages
  • 00Eligibility check
  • 01Baseline scan
  • 02Nodule surveillance
  • 03Early resection
LC-36moderate Impact

Quit-Smoking Dividend

Quitting by ~40 recovers ~9 of the 10 years smoking costs (Jha 2013). It is never too late to gain years.

Key signs
  • Pack-year count
  • Cigars count too
  • Beta-carotene supplements HARM smokers (ATBC)
  • Support doubles quit rates
Stages
  • 00Contemplation
  • 01Quit attempt
  • 021 year smoke-free
  • 03Risk falling every year
10 / ONCOLOGY

Oncology · Colorectal cancer

4 Conditions
CR-37high Impact

Adenoma → Carcinoma Sequence

Most bowel cancers grow from benign polyps over 10-15 years (Vogelstein) — removing the polyp prevents the cancer.

Key signs
  • Often silent for years
  • Polyps on colonoscopy
  • APC → KRAS → TP53 progression
Stages
  • 00Small adenoma
  • 01Advanced adenoma
  • 02Early carcinoma
  • 03Invasive cancer
CR-38high Impact

Red Flags

Rectal bleeding, a month of changed bowel habit, or unexplained anaemia — never assume 'just piles'.

Key signs
  • Blood in stool
  • Persistent habit change
  • Iron-deficiency anaemia
  • Weight loss
  • Tenesmus
Stages
  • 00Symptom triage
  • 01FIT test
  • 02Urgent colonoscopy
  • 03Staging
CR-39moderate Impact

Screening Works

FOBT cut mortality 33% (Minnesota); colonoscopy removes the risk it finds (NordICC). A FIT kit takes 2 minutes at home.

Key signs
  • FIT from 45-50
  • Earlier with family history
  • Lynch/FAP programs
  • Attendance is everything
Stages
  • 00Home FIT
  • 01Colonoscopy if positive
  • 02Polypectomy
  • 03Surveillance
CR-40moderate Impact

Immunotherapy Era (dMMR)

In mismatch-repair-deficient rectal cancer, dostarlimab achieved 100% clinical complete response (Cercek 2022) — every tumour tested for MSI/MMR.

Key signs
  • MSI-high / dMMR biopsy
  • PD-1 blockade response
  • Organ preservation possible
Stages
  • 00Molecular testing
  • 01Immunotherapy
  • 02Watch-and-wait
  • 03Surgery if needed
Key literature · every claim above is sourced

No "studies have shown" without a study.

02
Poplin R, Varadarajan AV, Blumer K, et al. Prediction of cardiovascular risk factors from retinal fundus photographs via deep learning.
Nature Biomedical Engineering. 2018;2:158–164.
03
De Fauw J, Ledsam JR, Romera-Paredes B, et al. Clinically applicable deep learning for diagnosis and referral in retinal disease.
Nature Medicine. 2018;24:1342–1350.
04
Wagner SK, Fu DJ, Faes L, et al. Insights into systemic disease through retinal imaging-based oculomics.
Transl Vis Sci Technol. 2020;9(2):6.
05
Wong TY, Klein R, Couper DJ, et al. Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study.
Lancet. 2001;358(9288):1134–1140.
07
Age-Related Eye Disease Study 2 (AREDS2) Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration.
JAMA. 2013;309(19):2005–2015.
08
Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: topical medication delays or prevents primary open-angle glaucoma.
Arch Ophthalmol. 2002;120(6):701–713.
09
Sabanayagam C, Xu D, Ting DSW, et al. A deep learning algorithm to detect chronic kidney disease from retinal photographs.
Lancet Digital Health. 2020;2(6):e295–e302.
10
Koronyo Y, Biggs D, Barron E, et al. Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease.
JCI Insight. 2017;2(16):e93621.
11
Mitani A, Huang A, Venugopalan S, et al. Detection of anaemia from retinal fundus images via deep learning.
Nature Biomedical Engineering. 2020;4:18–27.
12
Zhu Z, Shi D, Guankai P, et al. Retinal age gap as a predictive biomarker for mortality risk.
Br J Ophthalmol. 2022;107(4):547–554.
Important. OCTON AI is a screening companion for early triage and education — not a substitute for ophthalmologist evaluation. Any moderate or higher finding should be confirmed by a clinician. Systemic (oculomics) risk signals are inferred biomarkers grounded in the literature above, not diagnoses.
OCTON

A neuromorphic retinal screening engine. Fast pattern triage by the Hippocampus module, deep diagnostic reasoning by the Neocortex. For early detection of diabetic retinopathy, AMD, glaucoma & more.

For early screening — Not a substitute for a licensed ophthalmologist.

System
  • Hippocampus / OCTON Preliminary Analysis
  • Neocortex / OCTON In-Depth Analysis
© 2026 OCTON AIv1.0.0 / EARLY ACCESS
Install OCTON

Add OCTON to your home screen for faster captures and offline-ready scans.

AVA
Return to AVA